Zdrowie i gospodarka · 20/11/2023
FDA Announces Public Meeting on Rare Disease Patient Engagement
The FDA is hosting a public meeting to discuss how to better understand and involve rare disease patients in the drug development process, with a focus on their experiences and treatment goals.
Source: Federal Register — Food and Drug AdministrationOpen original release →